Skip to main content
SpringerLink
Log in

Basisbehandlung und Optionen bei Progredienz

Therapie der Trigeminus-Neuralgie

Trigeminal neuralgia: treatment options for refractory cases

  • FORTBILDUNG . SEMINAR
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Patienten, die von einer Trigeminus-Neuralgie geplagt werden, brauchen dringend eine wirksame Behandlung. Welche Basistherapie heute Standard ist und welche Optionen es für schwere, progrediente Verläufe gibt, wird im folgenden Beitrag dargestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Maarbjerg S, Di SG, Bendtsen L, Cruccu G (2017) Trigeminal neuralgia - diagnosis and treatment. Cephalalgia 37:648–657

    Article  Google Scholar 

  2. Obermann M, Holle D, Katsarava Z (2011) Trigeminal neuralgia and persistent idiopathic facial pain. Expert Rev Neurother 11:1619–1629

    Article  Google Scholar 

  3. Headache Classification Subcommittee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1–211

    Google Scholar 

  4. Antonini G, Di PA, Cruccu G, Truini A, Morino S, Saltelli G, Romano A, Trasimeni G, Vanacore N, Bozzao A (2014) Magnetic resonance imaging contribution for diagnosing symptomatic neurovascular contact in classical trigeminal neuralgia: a blinded case-control study and meta-analysis. Pain 155:1464–1471

    Article  Google Scholar 

  5. Maarbjerg S, Wolfram F, Gozalov A, Olesen J, Bendtsen L (2015) Significance of neurovascular contact in classical trigeminal neuralgia. Brain 138:311–319

    Article  Google Scholar 

  6. Leal PR, Barbier C, Hermier M, Souza MA, Cristino-Filho G, Sindou M (2014) Atrophic changes in the trigeminal nerves of patients with trigeminal neuralgia due to neurovascular compression and their association with the severity of compression and clinical outcomes. J Neurosurg 120:1484–1495

    Article  Google Scholar 

  7. Förderreuther S, Engelter S, Evers S, Paulus W, Tronnier V, Mitrovic N. (2012) Trigeminusneuralgie. Leitlinie der Deutschen Gesellschaft für Neurologie. https://www.dgn.org/leitlinien/2287-ll-58-2012-trigeminusneuralgie

  8. Elsner F, Radbruch L, Gaertner J, Straub U, Sabatowski R (2006) [Efficacy of opioid analgesia at the superior cervical ganglion in neuropathic head and facial pain]. Schmerz 20:268–6

    Article  CAS  Google Scholar 

  9. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL (1997) Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 73:223–230

    Article  CAS  Google Scholar 

  10. Lechin F, van der DB, Lechin ME, Amat J, Lechin AE, Cabrera A, Gomez F, Acosta E, Arocha L, Villa S, Jimenez V (1989) Pimozide therapy for trigeminal neuralgia. Arch Neurol 46:960–963

    Article  CAS  Google Scholar 

  11. Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ (2012) Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia 32:443–450

    Article  Google Scholar 

  12. Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N, Wu C (2014) Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. J Headache Pain 15:65

    Article  CAS  Google Scholar 

  13. Li S, Lian YJ, Chen Y, Zhang HF, Ma YQ, He CH, Wu CJ, Xie NC, Zheng YK, Zhang Y (2014) Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up. J Headache Pain 15:43

    Article  CAS  Google Scholar 

  14. Zakrzewska JM, Palmer J, Morisset V, Giblin GM, Obermann M, Ettlin DA, Cruccu G, Bendtsen L, Estacion M, Derjean D, Waxman SG, Layton G, Gunn K, Tate S (2017) Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol 16:291–300

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Neurologie, Klinikum der Ludwig-Maximilians-Universität München, Marchioninistr. 15, D-81377, München, Deutschland

    Ruth Ruscheweyh

  2. http://www.springermedizin.de

    A. Straube

Authors
  1. Ruth Ruscheweyh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Straube
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ruth Ruscheweyh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruscheweyh, R., Straube, A. Therapie der Trigeminus-Neuralgie. MMW - Fortschritte der Medizin 161, 52–56 (2019). https://doi.org/10.1007/s15006-019-0557-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-019-0557-x

Keywords

Search

Navigation